Methyl 5-chloro-2,4-difluorobenzoate, 95.0%, 25g

4-(2-oxo-1,2-dihydropyridin-1-yl)butanoic acid, 95.0%, 500mg

Tricosanoic Acid>95.0%(GC)(T)1g

(R)-tert-Butyl 2-(1,3-dioxoisoindolin-2-yloxy)-3-phenylpropanoate, 98%, 1g

GC capillary column ROTI®Cap-5, 50 m, 0.53 mm, 2.00 µm, 1 Piece(s)

(2S,5S)-tert-Butyl 2,5-dimethylpiperazine-1-carboxylate, 95.0%, 1g

3-CYCLOHEXYL-1H-INDOLE, 95%, 5g

AC-ALA-NHME, 97.0%, 250mg

(E)-1-Octadecyl-4-styrylpyridin-1-ium bromide, 95+%, 1g

(S)-1-(4-(tert-butyl)phenyl)ethan-1-amine hcl, 97%, 1g

(6-(Aminomethyl)pyridin-3-yl)boronic acid, 98%, 1g

1-(Tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 98%, 1g

2-Pyrrol-1-yl-benzoic acid hydrazide, 95.0%, 5g